Campbell & Co Investment Adviser’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-26,162
Closed -$491K – 1082
2022
Q4
$491K Buy
+26,162
New +$504K 0.12% 323
2022
Q3
– Sell
-16,558
Closed -$289K – 990
2022
Q2
$289K Buy
+16,558
New +$316K 0.08% 475
2021
Q4
– Sell
-24,300
Closed -$343K – 871
2021
Q3
$343K Buy
+24,300
New +$378K 0.11% 330
2018
Q4
– Sell
-25,952
Closed -$521K – 547
2018
Q3
$521K Buy
+25,952
New +$550K 0.35% 69
2015
Q2
– Sell
-35,021
Closed -$560K – 259
2015
Q1
$560K Buy
+35,021
New +$579K 0.35% 108

Other funds holding NXGN

Campbell & Co Investment Adviser's NXGN Position: Q1 2023 in Review

Campbell & Co Investment Adviser sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q1 2023, closing a stake of 26,162 shares — an estimated $491K sold.

Campbell & Co Investment Adviser first reported a position in NXGN in Q1 2015 and held it in 5 quarters. The position peaked at $560K in Q1 2015. 213 funds tracked by Wall St. Rank hold NXGN as of Q1 2023.

  • Campbell & Co Investment Adviser reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 26,162 NextGen Healthcare, Inc. Common Stock shares in Q1 2023, an estimated $491K.
  • Campbell & Co Investment Adviser first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's NextGen Healthcare, Inc. Common Stock position peaked at $560K in Q1 2015.
  • 213 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2023, filed 11 May 2023.